Strong growth in patient numbers drives performance at Calea

Calea UK, the home healthcare and pharmaceutical business owned by Fresenius, reported a 16% leap in turnover to £62.6m in the year to 31 December 2017. The directors said the improved performance had been driven by strong growth in patient numbers, which were up 13% on an annualised basis. Turnover growth was also achieved at…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »